Scientific ArticleRadiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma
Cited by (0)
Sources of support: This work is directly supported by the Andrew Sabin Family Foundation; Dr Fuller is a Sabin Family Foundation Fellow. Family of Paul W. Beach is providing direct salary support for Dr Kamal. Amit Jethanandani is supported by the Dunagan MD Medical Education Fund through The University of Tennessee Health Science Center, College of Medicine. Drs Yepes, Peeler, and Mirkovic are supported by Cancer Research Institute of Texas (CPRIT) award RP160232.
Disclosures: Drs. Mohamed, Hutcheson, and Fuller received funding support from the National Institutes of Health (NIH)/National Institute for Dental and Craniofacial Research (1R01DE025248-01/R56DE025248-01) and NIH/ National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148-01). Dr Fuller receives federal grant and salary support from the NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50CA097007-10) and a National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); the NCI QUBBD (1R01CA225190-01); the NIH Big Data to Knowledge (BD2K) Program of the NCI Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825-01); NCI Early Phase Clinical Trials in Imaging and Image Guided Interventions Program (1R01CA218148-01); a General Electric Healthcare/MD Anderson Center for Advanced Biomedical Imaging In-Kind Award; an Elekta AB/MD Anderson Department of Radiation Oncology Seed Grant; the Center for Radiation Oncology Research (CROR) at MD Anderson Cancer Center Seed Grant; and the MD Anderson Institutional Research Grant (IRG) Program and the Cancer center Support Grant Radiation Oncology/Cancer Imaging Program Seed Grant (5P30CA016672). Dr Fuller received industry grant support and speaker travel funding from Elekta AB.